{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:38:14Z","timestamp":1787611094496,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Uterine tumors resembling ovarian sex-cord tumors (UTROSCTs) are rare mesenchymal neoplasms predominantly arising in perimenopausal and postmenopausal women. UTROSCTs with growth regulation by estrogen in breast cancer 1 (\n                      <jats:italic>GREB1<\/jats:italic>\n                      )-rearrangement or\n                      <jats:italic>GREB1<\/jats:italic>\n                      -rearranged uterine tumors are exceptionally rare, with only 12 previously reported cases. Here, we report a case of UTROSCT with the\n                      <jats:italic>GREB1<\/jats:italic>\n                      -nuclear receptor coactivator 2 (\n                      <jats:italic>NCOA2<\/jats:italic>\n                      ) fusion gene.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 57-year-old woman presented with a 10.0\u2009cm uterine mass. The tumor was composed of short spindle or epithelioid cells, arranged in diffused sheets, nested, and trabecular\/cordlike. The tumor harbored the\n                      <jats:italic>GREB1-NCOA2<\/jats:italic>\n                      fusion gene, as confirmed by RNA sequencing. The tumor recurred in the pelvis at 30\u2009months after the initial diagnosis. We also compared the clinical and pathologic features of this case with those of the 12 previously published uterine\n                      <jats:italic>GREB1<\/jats:italic>\n                      -rearranged tumors. Of the combined 13 cases (present case and 12 previous cases), the mean age of patients was 64.8\u2009years (range, 51\u201374\u2009years). Of the nine reported cases of\n                      <jats:italic>GREB1<\/jats:italic>\n                      -rearranged tumor with follow up, four cases recurred or metastasized (44.4%). Microscopically, most tumors (10\/12, 83.3%) showed infiltrative growth, and two were well demarcated. Mitotic figures ranged from 0 to 14 per 10 high-power fields (2\u2009mm\n                      <jats:sup>2<\/jats:sup>\n                      ; mean: 3.6). Lymphovascular invasion and necrosis were each present in two cases (2\/12, 16.7% and 2\/7, 28.6%, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This case provided further evidence that UTROSCTs with\n                      <jats:italic>GREB1<\/jats:italic>\n                      -rearrangement may have a high risk of recurrence\/metastasis. Further studies are necessary to clarify the clinical features of this type of tumor, particularly the prognosis, potential treatment, and range of possible molecular events.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-020-01025-8","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T21:02:41Z","timestamp":1600030961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Recurrent uterine tumors resembling ovarian sex-cord tumors with the growth regulation by estrogen in breast cancer 1-nuclear receptor coactivator 2 fusion gene: a case report and literature review"],"prefix":"10.1186","volume":"15","author":[{"given":"Bin","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"1025_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/PAS.0000000000001348","volume":"44","author":"EA Goebel","year":"2020","unstructured":"Goebel EA, Hernandez Bonilla S, Dong F, Dickson BC, Hoang LN, Hardisson D, et al. Uterine tumor resembling ovarian sex cord tumor (UTROSCT): a morphologic and molecular study of 26 cases confirms recurrent NCOA1-3 rearrangement. Am J Surg Pathol. 2020;44:30\u201342.","journal-title":"Am J Surg Pathol"},{"key":"1025_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/PAS.0000000000001153","volume":"43","author":"BC Dickson","year":"2019","unstructured":"Dickson BC, Childs TJ, Colgan TJ, Sung YS, Swanson D, Zhang L, et al. Uterine tumor resembling ovarian sex cord tumor: a distinct entity characterized by recurrent NCOA2\/3 gene fusions. Am J Surg Pathol. 2019;43:178\u201386.","journal-title":"Am J Surg Pathol"},{"key":"1025_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/gcc.22694","volume":"58","author":"S Croce","year":"2019","unstructured":"Croce S, Lesluyes T, Delespaul L, Bonhomme B, Perot G, Velasco V, et al. GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): a novel CTNNB1 rearrangement. Genes Chromosom Cancer. 2019;58:155\u201363.","journal-title":"Genes Chromosom Cancer"},{"key":"1025_CR4","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/PAS.0000000000001265","volume":"43","author":"CH Lee","year":"2019","unstructured":"Lee CH, Kao YC, Lee WR, Hsiao YW, Lu TP, Chu CY, et al. Clinicopathologic characterization of GREB1-rearranged uterine sarcomas with variable sex-cord differentiation. Am J Surg Pathol. 2019;43:928\u201342.","journal-title":"Am J Surg Pathol"},{"key":"1025_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejogrb.2014.07.050","volume":"181","author":"EA Blake","year":"2014","unstructured":"Blake EA, Sheridan TB, Wang KL, Takiuchi T, Kodama M, Sawada K, et al. Clinical characteristics and outcomes of uterine tumors resembling ovarian sex-cord tumors (UTROSCT): a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014;181:163\u201370.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1025_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/his.13296","volume":"71","author":"M Moore","year":"2017","unstructured":"Moore M, McCluggage WG. Uterine tumour resembling ovarian sex cord tumour: first report of a large series with follow-up. Histopathology. 2017;71:751\u20139.","journal-title":"Histopathology."},{"key":"1025_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/PAS.0000000000001396","volume":"44","author":"B Chang","year":"2020","unstructured":"Chang B, Yu L, Guo WW, Sheng WQ, Wang L, Lao I, et al. Malignant gastrointestinal Neuroectodermal tumor: clinicopathologic, immunohistochemical, and molecular analysis of 19 cases. Am J Surg Pathol. 2020;44:456\u201366.","journal-title":"Am J Surg Pathol"},{"key":"1025_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.humpath.2017.04.022","volume":"69","author":"K Inamura","year":"2017","unstructured":"Inamura K, Kobayashi M, Nagano H, Sugiura Y, Ogawa M, Masuda H, et al. A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder. Hum Pathol. 2017;69:96\u2013100.","journal-title":"Hum Pathol"},{"key":"1025_CR9","unstructured":"Oliva E, Carcangiu, M.L., Carinelli S.G., Loening T. Longacre T.A., Nucci M.R. et al., Tumor of the uterine corpus, mesenchymal tumors. In: Kurman RJ, Carcangiu, M.L., Herrington, C.S., Young, R.H., etitors. WHO classification of tumors of female reproductive organs. 4th edn. Lyon, Academic; 2014; p. 145."},{"key":"1025_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/gcc.22649","volume":"57","author":"BC Dickson","year":"2018","unstructured":"Dickson BC, Lum A, Swanson D, Bernardini MQ, Colgan TJ, Shaw PA, et al. Novel EPC1 gene fusions in endometrial stromal sarcoma. Genes Chromosom Cancer. 2018;57:598\u2013603.","journal-title":"Genes Chromosom Cancer"},{"key":"1025_CR11","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1073\/pnas.101132598","volume":"98","author":"JI Koontz","year":"2001","unstructured":"Koontz JI, Soreng AL, Nucci M, Kuo FC, Pauwels P, van Den Berghe H, et al. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A. 2001;98:6348\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1025_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/his.12594","volume":"67","author":"CH Lee","year":"2015","unstructured":"Lee CH, Nucci MR. Endometrial stromal sarcoma--the new genetic paradigm. Histopathology. 2015;67:1\u201319.","journal-title":"Histopathology."},{"key":"1025_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2014.01.030","volume":"347","author":"F Micci","year":"2014","unstructured":"Micci F, Gorunova L, Gatius S, Matias-Guiu X, Davidson B, Heim S, et al. MEAF6\/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma. Cancer Lett. 2014;347:75\u20138.","journal-title":"Cancer Lett"},{"key":"1025_CR14","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/ijc.28440","volume":"134","author":"B Dewaele","year":"2014","unstructured":"Dewaele B, Przybyl J, Quattrone A, Finalet Ferreiro J, Vanspauwen V, Geerdens E, et al. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma. Int J Cancer. 2014;134:1112\u201322.","journal-title":"Int J Cancer"},{"key":"1025_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/PAP.0000000000000046","volume":"21","author":"CM Conklin","year":"2014","unstructured":"Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol. 2014;21:383\u201393.","journal-title":"Adv Anat Pathol"},{"key":"1025_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PAS.0000000000000721","volume":"41","author":"LN Hoang","year":"2017","unstructured":"Hoang LN, Aneja A, Conlon N, Delair DF, Middha S, Benayed R, et al. Novel high-grade endometrial stromal sarcoma: a morphologic mimicker of Myxoid Leiomyosarcoma. Am J Surg Pathol. 2017;41:12\u201324.","journal-title":"Am J Surg Pathol"},{"key":"1025_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/PGP.0000000000000554","volume":"38","author":"WG McCluggage","year":"2019","unstructured":"McCluggage WG, Lee CH. YWHAE-NUTM2A\/B translocated high-grade endometrial stromal sarcoma commonly expresses CD56 and CD99. Int J Gynecol Pathol. 2019;38:528\u201332.","journal-title":"Int J Gynecol Pathol"},{"key":"1025_CR18","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/modpathol.2013.69","volume":"26","author":"S Croce","year":"2013","unstructured":"Croce S, Hostein I, Ribeiro A, Garbay D, Velasco V, Stoeckle E, et al. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations. Mod Pathol. 2013;26:1390\u2013400.","journal-title":"Mod Pathol"},{"key":"1025_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/gcc.22518","volume":"57","author":"M Brunetti","year":"2018","unstructured":"Brunetti M, Panagopoulos I, Gorunova L, Davidson B, Heim S, Micci F. RNA-sequencing identifies novel GREB1-NCOA2 fusion gene in a uterine sarcoma with the chromosomal translocation t(2;8)(p25;q13). Genes Chromosom Cancer. 2018;57:176\u201381.","journal-title":"Genes Chromosom Cancer"},{"key":"1025_CR20","doi-asserted-by":"publisher","unstructured":"Bennett JA, Lastra RR, Barroeta JE, Parilla M, Galbo F, Wanjari P, Young RH, Krausz T, Oliva E. Uterine tumor resembling ovarian sex cord stromal tumor (UTROSCT): a series of 3 cases with extensive rhabdoid differentiation, malignant behavior, and ESR1-NCOA2 fusions. Am J Surg Pathol. 2020. https:\/\/doi.org\/10.1097\/PAS.0000000000001543 Online ahead of print.","DOI":"10.1097\/PAS.0000000000001543"},{"key":"1025_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.celrep.2013.01.010","volume":"3","author":"H Mohammed","year":"2013","unstructured":"Mohammed H, D'Santos C, Serandour AA, Ali HR, Brown GD, Atkins A, et al. Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep. 2013;3:342\u20139.","journal-title":"Cell Rep"},{"key":"1025_CR22","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.3390\/ijms19092543","volume":"19","author":"M Cheng","year":"2018","unstructured":"Cheng M, Michalski S, Kommagani R. Role for growth regulation by estrogen in breast cancer 1 (GREB1) in hormone-dependent cancers. Int J Mol Sci. 2018;19:2543.","journal-title":"Int J Mol Sci"},{"key":"1025_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41416-018-0345-x","volume":"120","author":"E Lopez-Knowles","year":"2019","unstructured":"Lopez-Knowles E, Pearson A, Schuster G, Gellert P, Ribas R, Yeo B, et al. Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations. Br J Cancer. 2019;120:247\u201355.","journal-title":"Br J Cancer"},{"key":"1025_CR24","doi-asserted-by":"publisher","first-page":"313ra182","DOI":"10.1126\/scitranslmed.aac7551","volume":"7","author":"G Schiavon","year":"2015","unstructured":"Schiavon G, Hrebien S, Garcia-Murillas I, Cutts RJ, Pearson A, Tarazona N, et al. Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer. Sci Transl Med. 2015;7:313ra182.","journal-title":"Sci Transl Med"},{"key":"1025_CR25","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.prp.2019.01.039","volume":"215","author":"D Segala","year":"2019","unstructured":"Segala D, Gobbo S, Pesci A, Martignoni G, Santoro A, Angelico G, et al. Tamoxifen related uterine tumor resembling ovarian sex cord tumor (UTROSCT): a case report and literature review of this possible association. Pathol Res Pract. 2019;215:1089\u201392.","journal-title":"Pathol Res Pract"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-01025-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-020-01025-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-01025-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T19:51:29Z","timestamp":1631562689000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-020-01025-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1025"],"URL":"https:\/\/doi.org\/10.1186\/s13000-020-01025-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-40713\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-40713\/v2","asserted-by":"object"}]},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"7 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this manuscript obtained patient consent for publication of clinical data and images. The patient\u2019s details were anonymized, and the patient signed a consent form for publication. Due to the retrospective and noninterventional nature of the study, permission by the local ethics committee was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors of this manuscript obtained patient consent for publication of clinical data and images. The patient details were anonymized, and the patient signed a consent form for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}